Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Almirall's Days Payable or its related term are showing as below:
FRA:E2Z'
s Days Payable Range Over the Past 10 Years
Min: 169.7 Med: 366.91 Max: 518.63
Current: 169.7
During the past 13 years, Almirall's highest Days Payable was 518.63. The lowest was 169.70. And the median was 366.91.
FRA:E2Z's Days Payable is ranked better than 79.37% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.22
vs FRA:E2Z: 169.70
Almirall's Days Payable
declined
from Jun. 2025 (742.35) to Jun. 2026 (0.00).
It may suggest that Almirallaccelerated paying its suppliers.
Almirall Days Payable Related Terms
Almirall Days Payable Historical Data
* Premium members only.
The historical data trend for Almirall's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:E2Z vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almirall Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Almirall's Days Payable distribution charts can be found below:
* The bar in red indicates where Almirall's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Almirall's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almirall (FRA:E2Z) has a Days Payable of 0.00 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Almirall and its competitors. Over the past decade, Almirall's Days Payable has ranged from 169.70 to 518.63. According to the industry distribution chart, Almirall ranks #191 out of 926 companies in the Drug Manufacturers industry, placing it in the top 20.6%.
Is Almirall's Days Payable too high?
Almirall's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 169.70 to a high of 518.63. Based on the distribution chart, Almirall ranks #191 out of 926 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Almirall has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Almirall's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Almirall ranks #191 out of 926 companies for Days Payable. This places Almirall in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.22. Historically, Almirall's own Days Payable has ranged from 169.70 to 518.63 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Almirall and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almirall's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Based on GuruFocus' analysis, Almirall (FRA:E2Z) is currently considered Fairly Valued. The stock's GF Value™ is €12.22, compared to a current price of €11.06 — trading 9.5% below its estimated fair value. The current Days Payable is 0.00. Almirall's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Almirall (FRA:E2Z), the current Days Payable is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Almirall (FRA:E2Z) Overvalued in 2026?
Based on GuruFocus' analysis, Almirall stock appears to be undervalued.
The current stock price of €11.06 is trading 9.5% below its estimated GF Value™ of €12.22.
GuruFocus considers Almirall to be Fairly Valued.
Key valuation signals for FRA:E2Z:
Days Payable: 0.00
GF Value™: €12.22 vs. price of €11.06 (9.5% below fair value)
No single metric tells the full story. See the FRA:E2Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
86GF Score
Get the complete analysis for FRA:E2Z
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E2Z has been successfully added to your 
